Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huidong Gu

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Clinical Therapeutics|March 3, 2012
Multicenter, randomized, double-blind, placebo-controlled, single-ascending dose study of the oral γ-secretase inhibitor BMS-708163 (Avagacestat): tolerability profile, pharmacokinetic parameters, and pharmacodynamic markersGary Tong, Jun-Sheng Wang, Oleksandr Sverdlov, et al.
Analytical Chemistry|June 29, 2019
Determination of Real Time in Vivo Drug Receptor Occupancy for a Covalent Binding Drug as a Clinical Pharmacodynamic Biomarker by Immunocapture-LC-MS/MSNaiyu Zheng, Ian M Catlett, Kristin Taylor, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 30, 2017
Role of regional absorption and gastrointestinal motility on variability in oral absorption of a model drugAjit S Narang, Anand Balakrishnan, John Morrison, et al.
Bioanalysis|June 10, 2016
Antibody-drug conjugate bioanalysis using LB-LC-MS/MS hybrid assays: strategies, methodology and correlation to ligand-binding assaysJian Wang, Huidong Gu, Ang Liu, et al.
Bioanalysis|July 31, 2015
An integrated multiplatform bioanalytical strategy for antibody-drug conjugates: a novel case studyHeather Myler, Vangipuram S Rangan, Jian Wang, et al.
Cell Metabolism|November 2, 2022
MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesityDong Cheng, Bradley A Zinker, Yi Luo, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Clinical Therapeutics|March 3, 2012
Multicenter, randomized, double-blind, placebo-controlled, single-ascending dose study of the oral γ-secretase inhibitor BMS-708163 (Avagacestat): tolerability profile, pharmacokinetic parameters, and pharmacodynamic markersGary Tong, Jun-Sheng Wang, Oleksandr Sverdlov, et al.
Analytical Chemistry|June 29, 2019
Determination of Real Time in Vivo Drug Receptor Occupancy for a Covalent Binding Drug as a Clinical Pharmacodynamic Biomarker by Immunocapture-LC-MS/MSNaiyu Zheng, Ian M Catlett, Kristin Taylor, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 30, 2017
Role of regional absorption and gastrointestinal motility on variability in oral absorption of a model drugAjit S Narang, Anand Balakrishnan, John Morrison, et al.
Bioanalysis|June 10, 2016
Antibody-drug conjugate bioanalysis using LB-LC-MS/MS hybrid assays: strategies, methodology and correlation to ligand-binding assaysJian Wang, Huidong Gu, Ang Liu, et al.
Bioanalysis|July 31, 2015
An integrated multiplatform bioanalytical strategy for antibody-drug conjugates: a novel case studyHeather Myler, Vangipuram S Rangan, Jian Wang, et al.
Cell Metabolism|November 2, 2022
MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesityDong Cheng, Bradley A Zinker, Yi Luo, et al.
Pageof 4